Trial Profile
A Multicenter, Parallel-group, Double-blind, Placebo Controlled and Randomized Clinical Study to Assess the Efficacy and Safety of Ketoprofen 10% Cutaneous Spray versus Placebo in Patients with Acute Ankle Sprains (AAS).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Feb 2017
Price :
$35
*
At a glance
- Drugs Ketoprofen (Primary)
- Indications Ankle injuries
- Focus Therapeutic Use
- Sponsors CSC Pharmaceuticals Handels
- 31 May 2011 New trial record